Authors:
Shappell, SB
Manning, S
Boeglin, WE
Guan, YF
Roberts, RL
Davis, L
Olson, SJ
Jack, GS
Coffey, CS
Wheeler, TM
Breyer, MD
Brash, AR
Citation: Sb. Shappell et al., Alterations in lipoxygenase and cyclooxygenase-2 catalytic activity and mRNA expression in prostate carcinoma, NEOPLASIA, 3(4), 2001, pp. 287-303
Authors:
Grossklaus, DJ
Coffey, CS
Shappell, SB
Jack, GS
Cookson, MS
Citation: Dj. Grossklaus et al., Prediction of tumour volume and pathological stage in radical prostatectomy specimens is not improved by taking more prostate needle-biopsy cores, BJU INT, 88(7), 2001, pp. 722-726
Authors:
Dutta, SC
Smith, JA
Shappell, SB
Coffey, CS
Chang, SS
Cookson, MS
Citation: Sc. Dutta et al., Clinical under staging of high risk nonmuscle invasive urothelial carcinoma treated with radical cystectomy, J UROL, 166(2), 2001, pp. 490-493
Authors:
Grossklaus, DJ
Shappell, SB
Gautam, S
Smith, JA
Cookson, MS
Citation: Dj. Grossklaus et al., Ratio of free-to-total prostate specific antigen correlates with tumor volume in patients with increased prostate specific antigen, J UROL, 165(2), 2001, pp. 455-458
Authors:
Shappell, SB
Keeney, DS
Zhang, J
Page, R
Olson, SJ
Brash, AR
Citation: Sb. Shappell et al., 15-lipoxygenase-2 expression in benign and neoplastic sebaceous glands andother cutaneous adnexa, J INVES DER, 117(1), 2001, pp. 36-43
Authors:
Masumori, N
Thomas, TZ
Chaurand, P
Case, T
Paul, M
Kasper, S
Caprioli, RM
Tsukamoto, T
Shappell, SB
Matusik, RJ
Citation: N. Masumori et al., A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential, CANCER RES, 61(5), 2001, pp. 2239-2249
Authors:
Shappell, SB
Gupta, RA
Manning, S
Whitehead, R
Boeglin, WE
Schneider, C
Case, T
Price, J
Jack, GS
Wheeler, TM
Matusik, RJ
Brash, AR
DuBois, RN
Citation: Sb. Shappell et al., 15S-hydroxyeicosatetraenoic acid activates peroxisome proliferator-activated receptor gamma and inhibits proliferation in PC3 prostate carcinoma cells, CANCER RES, 61(2), 2001, pp. 497-503
Authors:
Jack, GS
Brash, AR
Olson, SJ
Manning, S
Coffey, CS
Smith, JA
Shappell, SB
Citation: Gs. Jack et al., Reduced 15-lipoxygenase-2 immunostaining in prostate adenocarcinoma: Correlation with grade and expression in high-grade prostatic intraepithelial neoplasia, HUMAN PATH, 31(9), 2000, pp. 1146-1154
Citation: Sb. Shappell et al., Expression of adhesion molecules in kidney with experimental chronic obstructive uropathy: The pathogenic role of ICAM-1 and VCAM-1, NEPHRON, 85(2), 2000, pp. 156-166
Authors:
Komhoff, M
Guan, YF
Shappell, HW
Davis, L
Jack, G
Shyr, Y
Koch, MO
Shappell, SB
Breyer, MD
Citation: M. Komhoff et al., Enhanced expression of cyclooxygenase-2 in high grade human transitional cell bladder carcinomas, AM J PATH, 157(1), 2000, pp. 29-35
Authors:
Shappell, SB
Boeglin, WE
Olson, SJ
Kasper, S
Brash, AR
Citation: Sb. Shappell et al., 15-lipoxygenase-2 (15-LOX-2) is expressed in benign prostatic epithelium and reduced in prostate adenocarcinoma, AM J PATH, 155(1), 1999, pp. 235-245